Boehringer Ingelheim has tapped RetinAI to support its attempt to develop treatments for geog | Boehringer Ingelheim has tapped RetinAI to support its attempt to develop treatments for geographic atrophy, striking a deal to apply AI tools to its imaging data in a search for novel biomarkers and predictors of disease progression.
